NCT05508061View on ClinicalTrials.gov

Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

March 16, 2023

Study Completion Date

March 16, 2023

Conditions
Type 1 Diabetes
Interventions
DRUG

Insulin Lispro Cartridge [Lyumjev]

Administration of Lyumjev in combination with the AP system

DRUG

Insulin Lispro Cartridge

Administration of Humalog in combination with the AP system (standard therapy)

Trial Locations (3)

6815 AD

Rijnstate Hospital, Arnhem

7009 BL

Slingeland Hospital, Doetinchem

6716 RP

Hospital Gelderse Vallei, Ede

Sponsors
All Listed Sponsors
lead

Inreda Diabetic B.V.

INDUSTRY